FOLFIRINOX Improves PFS Compared with Gemcitabine in Patients with Locally Advanced Pancreatic Carcinoma By Ogkologos - May 26, 2025 566 0 Facebook Twitter Google+ Pinterest WhatsApp Findings from the PRODIGE 29-UCGI 26 (NEOPAN) study Source RELATED ARTICLESMORE FROM AUTHOR New Targeted Therapy Shows Promising Early Results in Advanced Pancreatic Cancer FDA Approves Pivekimab Sunirine-pvzy for Blastic Plasmacytoid Dendritic Cell Neoplasm, an Ultra-Rare Haematologic Malignancy Ivonescimab Plus Chemotherapy Improves OS Compared with Tislelizumab Plus Chemotherapy in Previously Untreated Patients with Advanced Squamous NSCLC MOST POPULAR FDA Approves Dostarlimab-gxly with Chemotherapy for Endometrial Cancer August 11, 2023 Bus Driver Wears Different Costume Each Day To Make Kids Smile... January 27, 2022 EMA Recommends Extension of Indications for Serplulimab April 22, 2026 The UK Government’s response to Javed Khan’s tobacco review: A small... April 11, 2023 Load more HOT NEWS Selpercatinib Shows Promise against Lung Cancers with Alterations in RET Gene Long-Term Follow-Up Confirms a Sustained Reduction in Deaths from Prostate Cancer... Foodie Fridays: Apple Bok Choy Salad Cancer.Net’s 20th Anniversary: Celebrating Our Mission of Providing Trustworthy Cancer Information
